| Literature DB >> 31636287 |
María Pereda1,2, Ignacio Tamarit3,4, Alberto Antonioni4, Jose A Cuesta3,4,5,6, Penélope Hernández3,7, Angel Sánchez3,4,5,6.
Abstract
The problem of public good provision is central in economics and touches upon many challenging societal issues, ranging from climate change mitigation to vaccination schemes. However, results which are supposed to be applied to a societal scale have only been obtained with small groups of people, with a maximum group size of 100 being reported in the literature. This work takes this research to a new level by carrying out and analysing experiments on public good games with up to 1000 simultaneous players. The experiments are carried out via an online protocol involving daily decisions for extended periods. Our results show that within those limits, participants' behaviour and collective outcomes in very large groups are qualitatively like those in smaller ones. On the other hand, large groups imply the difficulty of conveying information on others' choices to the participants. We thus consider different information conditions and show that they have a drastic effect on subjects' contributions. We also classify the individual decisions and find that they can be described by a moderate number of types. Our findings allow to extend the conclusions of smaller experiments to larger settings and are therefore a relevant step forward towards the understanding of human behaviour and the organisation of our society.Entities:
Mesh:
Year: 2019 PMID: 31636287 PMCID: PMC6803689 DOI: 10.1038/s41598-019-50964-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Average cooperation values per round and per treatment. Error bars are not shown because de distributions of contributions per round are not unimodal; for a representation of dispersion, we point the reader to Fig. 2. In all PGG treatments, the endowment was 10 points, and they had to decide how many of them (0, 2, 4, 6, 8, 10) wanted to contribute to the common pool. The MPCR was 0.1 for all experiments, except for the PGG1000 were it was 0.01.
Figure 2Evolution of the frequency of different decisions per round (heatmap) along with the average contribution (black line), for (a) PGG100, (b) PGG1000, (c) PGG_HM, (d) PGG_HM2, (e) PGG_H, (f) PGG_H2. In the heatmap, yellowish (redish) squares correspond to low (high) frequencies (see scale).
Figure 3Jensen-Shannon distance of distribution of decisions per round, each pair of control-treatment.
Figure 4Percentage of free riders per round.
Figure 5Percentage of full cooperators per round.
Percentage of monotonous players in the experiments.
| PGG100 | PGG1000 | PGG_HM | PGG_HM2 | PGG_H | PGG_H2 |
|---|---|---|---|---|---|
| 0.188 | 0.160 | 0.141 | 0.152 | 0.160 | 0.192 |
Percentages of generous and non-generous people per experiment.
| PGG100 | PGG1000 | PGG_HM | PGG_HM2 | PGG_H | PGG_H2 | |
|---|---|---|---|---|---|---|
| all contributions > = 80% endowment | 0.09 | 0.09 | 0.18 | 0.10 | 0.21 | 0.15 |
| all contributions < = 20% endowment | 0.15 | 0.13 | 0.04 | 0.14 | 0.07 | 0.13 |
Percentage of people whose decisions were (not) correlated or Granger-caused by the group contributions. Significance level α = 0.05.
| PGG100 | PGG1000 | PGG_HM | PGG_HM2 | PGG_H | PGG_H2 | |
|---|---|---|---|---|---|---|
| Significantly correlated with the mean contribution of the group | 0.3168 | 0.3791 | 0.402 | 0.3824 | 0.3137 | 0.4216 |
| Significantly correlated with the modal contribution of the group | 0.1881 | 0.2975 | 0.3431 | 0.3235 | 0.3137 | 0.402 |
| Significantly correlated with the second most frequent contribution of the group | 0.1584 | 0.3244 | 0.2451 | 0.2941 | 0.2451 | 0.3039 |
| Not significantly correlated with the mean, modal or second most frequent contribution of the group | 0.6436 | 0.5821 | 0.5196 | 0.5588 | 0.4608 | 0.5 |
| Not Granger-caused by the group mean contribution or the modal contribution | 0.6941 | 0.9268 | 0.7176 | 0.6975 | 0.7021 | 0.7145 |
Figure 6Dropouts rate per round and per treatment.
Percentage of female and ranges of age of participants.
| Treatment | PGG100 | PGG1000 | PGG_HM | PGG_HM2 | PGG_H | PGG_H2 |
|---|---|---|---|---|---|---|
| % Females | 54% | 61.1% | 70.3% | 65.3% | 63% | 55.4% |
| Age range | 20–54 | 19–69 | 20–74 | 18–64 | 19–61 | 18–60 |